Flonase and Cabergoline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flonase (fluticasone propionate) and Cabergoline (cabergoline). Common drug interactions include therapeutic response unexpected among females and nasal congestion among males.

The phase IV clinical study analyzes what interactions people have when they take Flonase and Cabergoline. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.

What is Cabergoline?

Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 6,257 Cabergoline users. Check the latest studies of Cabergoline.

On Jul, 11, 2026

37 people who take Flonase and Cabergoline together, and have interactions are studied.

Flonase and Cabergoline drug interactions.

What are the common drug interactions of Flonase and Cabergoline, by gender? *:

female:

Therapeutic response unexpected
Throat irritation
Urticaria (rash of round, red welts on the skin that itch intensely)
Uterine polyp (a mass in the inner lining of the uterus)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Constipation
Nausea (feeling of having an urge to vomit)
Wheezing (a high-pitched whistling sound made while you breath)
Arthralgia (joint pain)
Asthma

male:

Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Cough
Diarrhoea
Disease recurrence
Dysgeusia (disorder of the sense of taste)
Epigastric discomfort
Fatigue (feeling of tiredness)
Headache (pain in head)
Localised infection (infection at the single location)

What are the common drug interactions of Flonase and Cabergoline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain
Acne (skin problems that cause pimples)
Application site erythema (redness of the skin at application site)
Application site irritation
Application site pruritus (application site severe itching of the skin)
Application site rash
Drug ineffective
Eating disorder
Menstruation irregular

30-39:

Fatigue (feeling of tiredness)
Arthralgia (joint pain)
Chest discomfort
Cough
Decreased appetite
Disease recurrence
Dysgeusia (disorder of the sense of taste)
Headache (pain in head)
Menstrual disorder (disease of menstrual cycle)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)

40-49:

Asthma
Cytomegalovirus infection
Drug hypersensitivity
Hypotension (abnormally low blood pressure)
Infection in an immunocompromised host
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Pneumonia
Renal transplant
Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

Constipation
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Arthralgia (joint pain)
Chronic kidney disease
Dysgeusia (disorder of the sense of taste)
Fatigue (feeling of tiredness)
Hyperhidrosis (abnormally increased sweating)
Hypoaesthesia (reduced sense of touch or sensation)
Pain

60+:

Memory impairment
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Confusional state
Constipation
Headache (pain in head)
Hypersensitivity
Hypoaesthesia (reduced sense of touch or sensation)
Injection site bruising
Injection site erythema (redness at injection site)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 18.92%
Multiple Myeloma (cancer of the plasma cells): 5 people, 13.51%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 13.51%
Drowsiness: 4 people, 10.81%
Asthma: 4 people, 10.81%
Nausea (feeling of having an urge to vomit): 3 people, 8.11%
Multiple Allergies (allergy to multiple agents): 3 people, 8.11%
Headache (pain in head): 3 people, 8.11%
Tumor: 2 people, 5.41%
Sleep Disorder: 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Flonase and Cabergoline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously